Xbiotech Stock Alpha and Beta Analysis
| XBIT Stock | USD 2.44 0.06 2.52% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as XBiotech. It also helps investors analyze the systematic and unsystematic risks associated with investing in XBiotech over a specified time horizon. Remember, high XBiotech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to XBiotech's market risk premium analysis include:
Beta 1.83 | Alpha (0.19) | Risk 4.76 | Sharpe Ratio 0.0005 | Expected Return 0.0023 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out XBiotech Backtesting, XBiotech Valuation, XBiotech Correlation, XBiotech Hype Analysis, XBiotech Volatility, XBiotech History and analyze XBiotech Performance. XBiotech Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. XBiotech market risk premium is the additional return an investor will receive from holding XBiotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in XBiotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate XBiotech's performance over market.| α | -0.19 | β | 1.83 |
XBiotech expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of XBiotech's Buy-and-hold return. Our buy-and-hold chart shows how XBiotech performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.XBiotech Market Price Analysis
Market price analysis indicators help investors to evaluate how XBiotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading XBiotech shares will generate the highest return on investment. By understating and applying XBiotech stock market price indicators, traders can identify XBiotech position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Inverse Tangent Over Price Movement | ||
| Price Ceiling Movement | ||
| Aroon Oscillator | ||
| Balance Of Power | ||
| Parabolic SAR | ||
| MidPoint over period | ||
| Stalled Pattern | ||
| Separating Lines |
XBiotech Return and Market Media
The median price of XBiotech for the period between Thu, Oct 9, 2025 and Wed, Jan 7, 2026 is 2.47 with a coefficient of variation of 5.97. The daily time series for the period is distributed with a sample standard deviation of 0.15, arithmetic mean of 2.46, and mean deviation of 0.11. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | XBiotech Share Price Crosses Below 50-Day Moving Average - Should You Sell - MarketBeat | 10/10/2025 |
2 | How XBiotech Inc. stock trades after rate cuts - 2025 Performance Recap Advanced Swing Trade Entry Plans - newser.com | 10/24/2025 |
3 | Can XBiotech Inc. stock sustain free cash flow - Quarterly Investment Review Weekly Hot Stock Watchlists - newser.com | 10/27/2025 |
4 | Will XBiotech Inc. stock outperform foreign stocks - July 2025 Trends Weekly Market Pulse Alerts - newser.com | 10/31/2025 |
5 | Is XBiotech Inc. stock near bottom after decline - Weekly Trade Recap Verified Momentum Watchlists - newser.com | 11/03/2025 |
6 | November 2025s Promising Penny Stocks To Watch | 11/12/2025 |
7 | XBiotech Releases Earnings Results - MarketBeat | 11/13/2025 |
8 | Is XBiotech Inc. stock a top hedge fund pick - Quarterly Earnings Summary High Yield Equity Trading Tips - newser.com | 11/18/2025 |
9 | How XBiotech Inc. stock gains from tech spending - 2025 Earnings Surprises Detailed Earnings Play Alerts - | 12/18/2025 |
10 | CEO Moves Will XBIT stock rally after Fed decisions - IPO Watch Detailed Earnings Play Strategies - moha.gov.vn | 12/29/2025 |
About XBiotech Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including XBiotech or other stocks. Alpha measures the amount that position in XBiotech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2025 | 2026 (projected) | Dividend Yield | 0.2 | 0.18 | Price To Sales Ratio | 23.98 | 14.88 |
XBiotech Upcoming Company Events
As portrayed in its financial statements, the presentation of XBiotech's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, XBiotech's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of XBiotech's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of XBiotech. Please utilize our Beneish M Score to check the likelihood of XBiotech's management manipulating its earnings.
| 3rd of January 2024 Upcoming Quarterly Report | View | |
| 30th of September 2023 Next Fiscal Quarter End | View |
Build Portfolio with XBiotech
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for XBiotech Stock Analysis
When running XBiotech's price analysis, check to measure XBiotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XBiotech is operating at the current time. Most of XBiotech's value examination focuses on studying past and present price action to predict the probability of XBiotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XBiotech's price. Additionally, you may evaluate how the addition of XBiotech to your portfolios can decrease your overall portfolio volatility.